Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0000097745-25-000175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-03 | 2025-12-01+ | TMO | Lowery Frederick M. | EVP | M - OptEx | $253.99 | +13.8K | 21.3K | +185% | +$3.51M |
| DM | 2025-12-03 | 2025-12-01+ | TMO | Lowery Frederick M. | EVP | S - Sale+OE | $589.81 | -13.8K | 14.4K | -49% | -$8.15M |
| DM | 2025-12-03 | 2025-12-01+ | TMO | Lowery Frederick M. | EVP | M - OptEx | $0.00 | -13.8K | 6,912 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | M | A | 6,912 | $253.99 | 21,279.37 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-01 | S | D | 6,913 | $597.68 | 14,367.37 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-01 | M | A | 6,913 | $253.99 | 21,280.37 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-02 | S | D | 6,912 | $581.94 | 14,367.37 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-12-02 | M | D | 6,912 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 6,912 Common Stock | (F4) The options vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-12-01 | M | D | 6,913 | $0.00 | 6,912 | D | $253.99 · — to 2026-02-26 | 6,913 Common Stock | (F4) The options vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |